Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial
about
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO ReportHow health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve.
P2860
Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Time to Definitive Health-Rela ...... ROX Randomized Phase III Trial
@ast
Time to Definitive Health-Rela ...... ROX Randomized Phase III Trial
@en
type
label
Time to Definitive Health-Rela ...... ROX Randomized Phase III Trial
@ast
Time to Definitive Health-Rela ...... ROX Randomized Phase III Trial
@en
prefLabel
Time to Definitive Health-Rela ...... ROX Randomized Phase III Trial
@ast
Time to Definitive Health-Rela ...... ROX Randomized Phase III Trial
@en
P2093
P2860
P50
P921
P1433
P1476
Time to Definitive Health-Rela ...... ROX Randomized Phase III Trial
@en
P2093
Benoist Chibaudel
Christophe Louvet
David Brusquant
Franck Bonnetain
Marine Hug de Larauze
Mohamed Hebbar
Zeinab Hamidou
P2860
P304
P356
10.1371/JOURNAL.PONE.0157067
P407
P577
2016-06-16T00:00:00Z